NEW AMSTERDAM PHARMA
NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
NEW AMSTERDAM PHARMA
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-01-01
Address:
Naarden, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.newamsterdampharma.com
Total Employee:
11+
Status:
Active
Total Funding:
160 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Current Advisors List
Current Employees Featured
Founder
Investors List
Presight Capital
Presight Capital investment in Series A - New Amsterdam Pharma
Ascendant BioCapital
Ascendant BioCapital investment in Series A - New Amsterdam Pharma
Medpace
Medpace investment in Series A - New Amsterdam Pharma
LSP BioVentures
LSP BioVentures investment in Series A - New Amsterdam Pharma
JVC Investment Partners
JVC Investment Partners investment in Series A - New Amsterdam Pharma
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals investment in Series A - New Amsterdam Pharma
Population Health Partners
Population Health Partners investment in Series A - New Amsterdam Pharma
Morningside Venture Investments
Morningside Venture Investments investment in Series A - New Amsterdam Pharma
Forbion Capital Partners
Forbion Capital Partners investment in Series A - New Amsterdam Pharma
Peter Thiel
Peter Thiel investment in Series A - New Amsterdam Pharma
Official Site Inspections
http://www.newamsterdampharma.com Semrush global rank: 2.54 M Semrush visits lastest month: 6.93 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "New Amsterdam Pharma"
NewAmsterdam Pharma: Science-Backed and Patient-Focused
We're advancing a new era of treatment for cardiovascular disease and other lipid-related conditions.See details»
About Us - New Amsterdam Pharma
Investors Overview — NewAmsterdam Pharma …
Nov 1, 2024 · Based in the Netherlands, NewAmsterdam (Nasdaq: NAMS) is a clinical-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved …See details»
NewAmsterdam Pharma: Contact Us
Oct 10, 2024 · [email protected] . Address NewAmsterdam Pharma Corporation 20803 Biscayne Blvd Suite #105 Aventura, FL 33180. Phone 1-305-627-3081See details»
NewAmsterdam Pharma Provides Corporate Update and Reports …
Aug 7, 2024 · NAARDEN, the Netherlands and MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the …See details»
NewAmsterdam Pharma Provides Corporate Update and Reports …
May 9, 2024 · NAARDEN, the Netherlands and MIAMI, May 09, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the …See details»
NewAmsterdam Pharma Provides Corporate Update and Reports …
NewAmsterdam is developing obicetrapib, an oral, low-dose and once-daily cholesteryl ester transfer protein (“CETP”) inhibitor, as the preferred LDL-C lowering therapy to be used as an …See details»
New Amsterdam Pharma - Crunchbase Company Profile & Funding
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases. View contacts for New Amsterdam …See details»
New Amsterdam Pharma - EQT Group
New Amsterdam Pharma is developing lipid-lowering therapies for diseases with large unmet need. Subscribe to EQT's press releases, regulatory press releases and updates.See details»
NewAmsterdam Pharma to Participate in Upcoming Medical and …
NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently …See details»
NewAmsterdam Pharma Debuts as Publicly Traded Company …
NAARDEN, the Netherlands and MIAMI, Nov. 23, 2022 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq:NAMS or “NewAmsterdam” or the “Company”), a clinical …See details»
Home — New Amsterdam Pharma
NewAmsterdam Pharma Corporation. 20803 Biscayne Blvd Suite #105. Aventura, FL 33180. Privacy PolicySee details»
NewAmsterdam Pharma Announces 2024 Strategic Priorities
Jan 4, 2024 · “NewAmsterdam is entering 2024 on the precipice of a major transformation, with the potential to deliver significant benefit to patients globally and create value for our …See details»
NewAmsterdam Pharma | Bain Capital Life Sciences
NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently …See details»
Press Release Details - ir.newamsterdampharma.com
Sep 30, 2024 · NewAmsterdam is developing obicetrapib, an oral, low-dose and once-daily cholesteryl ester transfer protein (“CETP”) inhibitor, as the preferred LDL-C lowering therapy to …See details»
NewAmsterdam Pharma Debuts as Publicly Traded Company
Nov 23, 2022 · NewAmsterdam (Nasdaq:NAMS) is a clinical-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where …See details»
NewAmsterdam Pharma Announces 2024 Strategic Priorities
Jan 4, 2024 · “NewAmsterdam is entering 2024 on the precipice of a major transformation, with the potential to deliver significant benefit to patients globally and create value for our …See details»
Maven Repository: org.jsoup » jsoup » 1.18.2
1 day ago · jsoup is a Java library that simplifies working with real-world HTML and XML. It offers an easy-to-use API for URL fetching, data parsing, extraction, and manipulation using DOM …See details»
NewAmsterdam Pharma: Clinical Trials and Expanded Access
Participating in clinical trials of investigational medicines may help contribute to the approval and availability of new treatments for patients in need, as these trials generate comprehensive data …See details»
Press Release Details - NewAmsterdam Pharma Company N.V.
NewAmsterdam (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved …See details»